THE GLYMPHATIC SYSTEM IN GLIOBLASTOMA: PROMISES AND PITFALLS

Abstract AIMS The glymphatic system, comprising perivascular spaces, astrocytic aquaporin-4 (AQP4) water channels, cere- brospinal fluid (CSF) and interstitial fluid (ISF), plays a crucial role in waste clearance, fluid homeostasis, and immune surveillance. Recognised as the brain’s “fourth circulation,” it has been implicated in several neurolog- ical diseases, although its role in glioblastoma remains poorly understood. Here we evaluate the interactions between glioblastoma and the glymphatic system, their implications for tumour progression, immune evasion, and drug delivery, and potential therapeutic strategies targeting glymphatic pathways. METHODS A systematic review of clinical and experimental studies was conducted to assess glymphatic dysfunction in glioblastoma. Key areas examined include its role in tumour spread, oedema formation, CSF dynamics, immune response and glymphatic-mediated drug delivery. The review also explores emerging therapeutic strategies targeting AQP4 and glymphatic flow to enhance immunotherapy and chemotherapy efficacy. RESULTS Glioblastoma disrupts glymphatic function by impairing its outflow as demonstrated using advanced MRI tech- niques, altering AQP4 polarisation, and increasing interstitial pressure. This dysfunction may explain the paradox of significant peritumoral oedema without hydrocephalus and the limited CSF-borne dissemination of glioblastoma. While glymphatic pathways facilitate cellular migration, including tumour infiltration along perivascular spaces, the “go or grow” hypothesis suggests that the most motile glioblastoma cells evade con- ventional therapies. Enhancing glymphatic flow could improve immune cell trafficking and synergise with immunotherapy. CONCLUSION The glymphatic system represents a promising yet complex target in glioblastoma therapy. Further mechanistic studies are needed to determine whether modulating glymphatic function can enhance treatment efficacy or inadvertently facilitate tumour invasion

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-09-01
DOI
https://doi.org/10.1093/neuonc/noaf185.119
Primary Topic
Cerebrospinal fluid and hydrocephalus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

THE GLYMPHATIC SYSTEM IN GLIOBLASTOMA: PROMISES AND PITFALLS

Keyoumars Ashkan, Ashwin Kumaria
1 links
Neuro-Oncology
Cerebrospinal fluid and hydrocephalus
article

THE GLYMPHATIC SYSTEM IN GLIOBLASTOMA: PROMISES AND PITFALLS

Keyoumars Ashkan, Ashwin Kumaria
article en

Abstract

Abstract AIMS The glymphatic system, comprising perivascular spaces, astrocytic aquaporin-4 (AQP4) water channels, cere- brospinal fluid (CSF) and interstitial fluid (ISF), plays a crucial role in waste clearance, fluid homeostasis, and immune surveillance. Recognised as the brain’s “fourth circulation,” it has been implicated in several neurolog- ical diseases, although its role in glioblastoma remains poorly understood. Here we evaluate the interactions between glioblastoma and the glymphatic system, their implications for tumour progression, immune evasion, and drug delivery, and potential therapeutic strategies targeting glymphatic pathways. METHODS A systematic review of clinical and experimental studies was conducted to assess glymphatic dysfunction in glioblastoma. Key areas examined include its role in tumour spread, oedema formation, CSF dynamics, immune response and glymphatic-mediated drug delivery. The review also explores emerging therapeutic strategies targeting AQP4 and glymphatic flow to enhance immunotherapy and chemotherapy efficacy. RESULTS Glioblastoma disrupts glymphatic function by impairing its outflow as demonstrated using advanced MRI tech- niques, altering AQP4 polarisation, and increasing interstitial pressure. This dysfunction may explain the paradox of significant peritumoral oedema without hydrocephalus and the limited CSF-borne dissemination of glioblastoma. While glymphatic pathways facilitate cellular migration, including tumour infiltration along perivascular spaces, the “go or grow” hypothesis suggests that the most motile glioblastoma cells evade con- ventional therapies. Enhancing glymphatic flow could improve immune cell trafficking and synergise with immunotherapy. CONCLUSION The glymphatic system represents a promising yet complex target in glioblastoma therapy. Further mechanistic studies are needed to determine whether modulating glymphatic function can enhance treatment efficacy or inadvertently facilitate tumour invasion

Neuro-OncologyVol. 27(Supplement_2)
King's College Hospital NHS Foundation Trust (GB), National Hospital for Neurology and Neurosurgery (GB), University College London (GB)
Openalex Percentile: Top 75%
Cerebrospinal fluid and hydrocephalus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.